Home/Filings/4/0001209191-18-049379
4//SEC Filing

SteadyMed Investors, LLC 4

Accession 0001209191-18-049379

CIK 0001619087other

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 7:43 PM ET

Size

12.4 KB

Accession

0001209191-18-049379

Insider Transaction Report

Form 4
Period: 2018-08-30
Transactions
  • Sale

    Ordinary Shares

    2018-08-30$4.46/sh266,257$1,187,5060 total(indirect: See Footnote.)
  • Sale

    Ordinary Shares

    2018-08-30$4.46/sh181,025$807,3720 total(indirect: See Footnote.)
  • Sale

    Ordinary Shares

    2018-08-30$4.46/sh2,088,258$9,313,6310 total(indirect: See Footnote.)
  • Other

    Warrants to Purchase Ordinary Shares

    2018-08-30$0.13/sh266,257$33,2820 total(indirect: See Footnote.)
    Exercise: $3.60Exp: 2021-08-03Ordinary Shares (266,527 underlying)
Footnotes (5)
  • [F1]Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation ("United"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the "Merger Agreement"). Under the Merger Agreement, at the effective time of the merger (the "Effective Time"), each outstanding ordinary share of the Issuer was converted into the right to receive (1) $4.46 in cash plus (2) one contractual contingent value right (a "CVR"), which represents the right to receive $2.63 in cash upon the achievement of a specified milestone (the "Milestone").
  • [F2]By SteadyMed Investors III LLC, an affiliate of SteadyMed Investors, LLC.
  • [F3]By SteadyMed Investors, LLC. KB Partners, LLC is the Managing Member and the Reporting Person is the Managing Member of KB Partners, LLC.
  • [F4]By SteadyMed Investors II, LLC, an affiliate of SteadyMed Investors LLC.
  • [F5]Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation ("United"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the "Merger Agreement"). At the Effective Time, each outstanding warrant to purchase ordinary shares of the Issuer issued in 2016 was converted into the right to receive $2.71.

Issuer

SteadyMed Ltd.

CIK 0001619087

Entity typeother
IncorporatedIL

Related Parties

1
  • filerCIK 0001637025

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 7:43 PM ET
Size
12.4 KB